Relationship Between Fibroblast Growth Factor 19 and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus

References

• Cheung N , Mitchell P , Wong TY . Diabetic retinopathy. Lancet . 2010;376(9735):124–136. doi:10.1016/S0140-6736(09)62124-3 20580421
   PubMed Web of Science ®Google Scholar
• Cheung N , Wong TY . Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res . 2008;27(2):161–176. doi:10.1016/j.preteyeres.2007.12.001 18249026
   PubMed Web of Science ®Google Scholar
• Drinkwater JJ , Davis TME , Hellbusch V , Turner AW , Bruce DG , Davis WA . Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle diabetes study phase II. Cardiovasc Diabetol . 2020;19(1):43. doi:10.1186/s12933-020-01018-3 32234054
   PubMed Web of Science ®Google Scholar
• Brown MM , Brown GC , Sharma S , Shah G . Utility values and diabetic retinopathy. Am J Ophthalmol . 1999;128(3):324–330. doi:10.1016/S0002-9394(99)00146-4 10511027
   PubMed Web of Science ®Google Scholar
• Itoh N , Ornitz DM . Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem . 2011;149(2):121–130. doi:10.1093/jb/mvq121 20940169
   PubMed Web of Science ®Google Scholar
• Jahn D , Rau M , Hermanns HM , Geier A . Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease. Cytokine Growth Factor Rev . 2015;26(6):625–635. doi:10.1016/j.cytogfr.2015.07.016 26250749
   PubMed Web of Science ®Google Scholar
• Stejskal D , Karpisek M , Hanulova Z , Stejskal P . Fibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test. Scand J Clin Lab Invest . 2008;68(6):501–507. doi:10.1080/00365510701854967 18609104
   PubMed Web of Science ®Google Scholar
• Hao Y , Zhou J , Zhou M , et al. Serum levels of fibroblast growth factor 19 are inversely associated with coronary artery disease in Chinese individuals. PLoS One . 2013;8(8):e72345. doi:10.1371/journal.pone.0072345 23940810
   PubMed Web of Science ®Google Scholar
• Tomlinson E , Fu L , John L , et al. Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology . 2002;143(5):1741–1747. doi:10.1210/endo.143.5.8850 11956156
   PubMed Web of Science ®Google Scholar
• Fu L , John LM , Adams SH , et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology . 2004;145(6):2594–2603. doi:10.1210/en.2003-1671 14976145
   PubMed Web of Science ®Google Scholar
• Fang Q , Li H , Song Q , et al. Serum fibroblast growth factor 19 levels are decreased in Chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levels. Diabetes Care . 2013;36(9):2810–2814. doi:10.2337/dc12-1766 23628619
   PubMed Web of Science ®Google Scholar
• Gerhard GS , Styer AM , Wood GC , et al. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass. Diabetes Care . 2013;36(7):1859–1864. doi:10.2337/dc12-2255 23801799
   PubMed Web of Science ®Google Scholar
• Siffroi-Fernandez S , Felder-Schmittbuhl MP , Khanna H , Swaroop A , Hicks D . FGF19 exhibits neuroprotective effects on adult mammalian photoreceptors in vitro. Invest Ophthalmol Vis Sci . 2008;49(4):1696–1704. doi:10.1167/iovs.07-1272 18385093
   PubMed Web of Science ®Google Scholar
• Somm E , Jornayvaz FR . Fibroblast growth factor 15/19: from basic functions to therapeutic perspectives. Endocr Rev . 2018;39(6):960–989. doi:10.1210/er.2018-00134 30124818
   PubMed Web of Science ®Google Scholar
• Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care . 2003;26(Suppl 1):S5–20. doi:10.2337/diacare.26.11.3160 12502614
   PubMed Web of Science ®Google Scholar
• Levey AS , Stevens LA , Schmid CH , et al. A new equation to estimate glomerular filtration rate. Ann Intern Med . 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006 19414839
   PubMed Web of Science ®Google Scholar
• Faul F , Erdfelder E , Lang AG , Buchner A . G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods . 2007;39(2):175–191. doi:10.3758/BF03193146 17695343
   PubMed Web of Science ®Google Scholar
• Barutcuoglu B , Basol G , Cakir Y , et al. Fibroblast growth factor-19 levels in type 2 diabetic patients with metabolic syndrome. Ann Clin Lab Sci . 2011;41(4):390–396.22166511
   PubMed Web of Science ®Google Scholar
• Liu WS , Tang MJ , Xu TL , et al. Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes. Diabetol Metab Syndr . 2020;12:44. doi:10.1186/s13098-020-00552-0 32477430
   PubMed Web of Science ®Google Scholar
• Wang D , Zhu W , Li J , An C , Wang Z . Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history. PLoS One . 2013;8(11):e81190. doi:10.1371/journal.pone.0081190 24260557
   PubMed Web of Science ®Google Scholar
• Xie MH , Holcomb I , Deuel B , et al. FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine . 1999;11(10):729–735. doi:10.1006/cyto.1999.0485 10525310
   PubMed Web of Science ®Google Scholar
• Dolegowska K , Marchelek-Mysliwiec M , Nowosiad-Magda M , Slawinski M , Dolegowska B . FGF19 subfamily members: FGF19 and FGF21. J Physiol Biochem . 2019;75(2):229–240. doi:10.1007/s13105-019-00675-7 30927227
   PubMed Web of Science ®Google Scholar
• Rani PK , Raman R , Gupta A , Pal SS , Kulothungan V , Sharma T . Albuminuria and diabetic retinopathy in type 2 diabetes mellitus Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study (SN-DREAMS, report 12). Diabetol Metab Syndr . 2011;3(1):9. doi:10.1186/1758-5996-3-9 21612596
   PubMed Web of Science ®Google Scholar
• Guo A , Li K , Xiao Q . Fibroblast growth factor 19 alleviates palmitic acid-induced mitochondrial dysfunction and oxidative stress via the AMPK/PGC-1alpha pathway in skeletal muscle. Biochem Biophys Res Commun . 2020;526(4):1069–1076. doi:10.1016/j.bbrc.2020.04.002 32305136
   PubMed Web of Science ®Google Scholar
• Fang Y , Zhao Y , He S , et al. Overexpression of FGF19 alleviates hypoxia/reoxygenation-induced injury of cardiomyocytes by regulating GSK-3beta/Nrf2/ARE signaling. Biochem Biophys Res Commun . 2018;503(4):2355–2362. doi:10.1016/j.bbrc.2018.06.161 29964017
   PubMed Web of Science ®Google Scholar
• You M , Zhou Z , Daniels M , Jogasuria A . Endocrine adiponectin-FGF15/19 axis in ethanol-induced inflammation and alcoholic liver injury. Gene Expr . 2018;18(2):103–113. doi:10.3727/105221617X15093738210295 29096734
   PubMedGoogle Scholar
• Gadaleta RM , Garcia-Irigoyen O , Cariello M , et al. Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X receptor. EBioMedicine . 2020;54:102719. doi:10.1016/j.ebiom.2020.102719 32259714
   PubMed Web of Science ®Google Scholar
• Davalos D , Akassoglou K . Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol . 2012;34(1):43–62. doi:10.1007/s00281-011-0290-8 22037947
   PubMed Web of Science ®Google Scholar
• Tang J , Kern TS . Inflammation in diabetic retinopathy. Prog Retin Eye Res . 2011;30(5):343–358. doi:10.1016/j.preteyeres.2011.05.002 21635964
   PubMed Web of Science ®Google Scholar
• Greco M , Chiefari E , Accattato F , et al. MicroRNA-1281 as a novel circulating biomarker in patients with diabetic retinopathy. Front Endocrinol (Lausanne) . 2020;11:528. doi:10.3389/fendo.2020.00528 32849308
   PubMed Web of Science ®Google Scholar